Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
| Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S |
| Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc. |
| 1:2022cv00464 |
| April 8, 2022 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 12, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 NOTICE of Withdrawal of Appearance by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc. of Ian R. Liston (Liston, Ian) |
| Filing 11 NOTICE of Appearance by Christine Dealy Haynes on behalf of Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc. (Haynes, Christine) |
| Filing 10 NOTICE of Appearance by Frederick L. Cottrell, III on behalf of Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc. (Cottrell, Frederick) |
SO ORDERED, re #9 STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to June 10, 2022, filed by Viatris Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. Reset Answer Deadlines: Mylan Pharmaceuticals Inc. answer due 6/10/2022; Viatris Inc. answer due 6/10/2022. Ordered by Judge Colm F. Connolly on 5/11/2022. (kmd)
|
| CORRECTING ENTRY: Party text for DI #9 has been modified per counsel's request. (mpb) |
| Filing 9 STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to June 10, 2022 - filed by Mylan Pharmaceuticals Inc., Viatris Inc.. (Liston, Ian) Modified on 5/11/2022 (mpb). |
| Filing 8 SUMMONS Returned Executed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Mylan Pharmaceuticals Inc. served on 4/20/2022, answer due 5/11/2022. (Mayo, Andrew) |
| Filing 7 SUMMONS Returned Executed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Viatris Inc. served on 4/20/2022, answer due 5/11/2022. (Mayo, Andrew) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (mal) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd.. (mal) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) see attached. (mal) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/24/2022. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 8/24/2024. (mal) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3847462.) - filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Attachments: #1 Exhibit A-M, #2 Civil Cover Sheet)(mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
